Instituto Rosenbusch S.A.
Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious kera… Read more
Market Cap & Net Worth: Instituto Rosenbusch S.A. (ROSE)
Instituto Rosenbusch S.A. (BA:ROSE) has a market capitalization of $7.86 Million (AR$8.18 Billion) as of March 18, 2026. Listed on the BA stock exchange, this Argentina-based company holds position #34911 globally and #61 in its home market, demonstrating a -10.07% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Instituto Rosenbusch S.A.'s stock price AR$192.00 by its total outstanding shares 42583417 (42.58 Million).
Instituto Rosenbusch S.A. Market Cap History: 2015 to 2026
Instituto Rosenbusch S.A.'s market capitalization history from 2015 to 2026. Data shows growth from $171.94K to $7.86 Million (43.74% CAGR).
Instituto Rosenbusch S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Instituto Rosenbusch S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Instituto Rosenbusch S.A.'s market cap is 0.00 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $171.94K | $135.49 Million | -$727.46K | 0.00x | N/A |
| 2016 | $249.72K | $167.31 Million | $10.16 Million | 0.00x | 0.02x |
| 2017 | $341.84K | $172.14 Million | -$72.31K | 0.00x | N/A |
| 2018 | $257.91K | $298.92 Million | $798.26K | 0.00x | 0.32x |
| 2019 | $229.26K | $411.82 Million | -$89.20 Million | 0.00x | N/A |
| 2020 | $470.79K | $558.63 Million | -$17.01 Million | 0.00x | N/A |
| 2021 | $450.32K | $781.61 Million | -$19.57 Million | 0.00x | N/A |
| 2022 | $528.11K | $1.37 Billion | -$8.10 Million | 0.00x | N/A |
| 2023 | $2.62 Million | $9.86 Billion | $1.23 Billion | 0.00x | 0.00x |
| 2024 | $4.99 Million | $8.27 Billion | -$1.42 Billion | 0.00x | N/A |
Competitor Companies of ROSE by Market Capitalization
Companies near Instituto Rosenbusch S.A. in the global market cap rankings as of March 18, 2026.
Key companies related to Instituto Rosenbusch S.A. by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Instituto Rosenbusch S.A. Historical Marketcap From 2015 to 2026
Between 2015 and today, Instituto Rosenbusch S.A.'s market cap moved from $171.94K to $ 7.86 Million, with a yearly change of 43.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AR$7.86 Million | -20.17% |
| 2025 | AR$9.85 Million | +97.13% |
| 2024 | AR$4.99 Million | +90.62% |
| 2023 | AR$2.62 Million | +396.12% |
| 2022 | AR$528.11K | +17.27% |
| 2021 | AR$450.32K | -4.35% |
| 2020 | AR$470.79K | +105.36% |
| 2019 | AR$229.26K | -11.11% |
| 2018 | AR$257.91K | -24.55% |
| 2017 | AR$341.84K | +36.89% |
| 2016 | AR$249.72K | +45.24% |
| 2015 | AR$171.94K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Instituto Rosenbusch S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.86 Million USD |
| MoneyControl | $7.86 Million USD |
| MarketWatch | $7.86 Million USD |
| marketcap.company | $7.86 Million USD |
| Reuters | $7.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.